Triple

T15921476
Position Surface form Disambiguated ID Type / Status
Subject CEP E386102 entity
Predicate issuedBy P29 FINISHED
Object European Directorate for the Quality of Medicines & HealthCare E12899 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Directorate for the Quality of Medicines & HealthCare | Statement: [CEP, issuedBy, European Directorate for the Quality of Medicines & HealthCare]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: European Directorate for the Quality of Medicines & HealthCare
Context triple: [CEP, issuedBy, European Directorate for the Quality of Medicines & HealthCare]
  • A. European Directorate for the Quality of Medicines & HealthCare chosen
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • B. European Union Drugs Agency
    The European Union Drugs Agency is the EU’s central body responsible for providing scientific analysis, monitoring, and policy support on drugs and drug addiction across member states.
  • C. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • D. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • E. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d86da686e4819097cbf3b1fc2d881d completed April 10, 2026, 3:25 a.m.
NER Named-entity recognition batch_69e156818cbc819086c956475ad23825 completed April 16, 2026, 9:37 p.m.
NED1 Entity disambiguation (via context triple) batch_69ffb5a96e508190a64c2be6dc506e86 completed May 9, 2026, 10:31 p.m.
Created at: April 10, 2026, 4:52 a.m.